Dr.Reddy’s gets board nod for ₹2,000 cr. borrowings

The board of directors of Dr. Reddy’s Laboratories on Friday gave its approval for the company to borrow up to ₹2,000 crore.

The borrowings can be either through issuance of commercial papers, debentures, bonds and or through bank credit lines, term loans, including external commercial borrowings, up to ₹2,000 crore, in one or more tranches. Dr.Reddy’s said in a stock exchange filing.

The board also approved the sale of the Contract Development and Manufacturing Organisation (CDMO) division of Custom Pharmaceutical Services (CPS) business of the company, to wholly owned step-down subsidiary, Aurigene Pharmaceutical Services (APSL), on slump sale basis, for a consideration of $72 million, the filing said.

A letter from the Editor

Dear reader,

We have been keeping you up-to-date with information on the developments in India and the world that have a bearing on our health and wellbeing, our lives and livelihoods, during these difficult times. To enable wide dissemination of news that is in public interest, we have increased the number of articles that can be read free, and extended free trial periods. However, we have a request for those who can afford to subscribe: please do. As we fight disinformation and misinformation, and keep apace with the happenings, we need to commit greater resources to news gathering operations. We promise to deliver quality journalism that stays away from vested interest and political propaganda.

Support Quality Journalism
Recommended for you
This article is closed for comments.
Please Email the Editor

Printable version | May 29, 2020 5:58:55 AM |

Next Story